U.S. Markets closed

BioLineRx Ltd. (BLRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.6700-0.0300 (-1.11%)
At close: 4:00PM EDT
2.6700 0.00 (0.00%)
After hours: 07:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.7000
Open2.7200
Bid2.6300 x 1800
Ask2.6800 x 800
Day's Range2.6100 - 2.7200
52 Week Range1.4000 - 6.3400
Volume318,511
Avg. Volume896,819
Market Cap123.33M
Beta (5Y Monthly)1.66
PE Ratio (TTM)N/A
EPS (TTM)-1.4400
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est14.50
  • PR Newswire

    BioLineRx Reports Second Quarter 2021 Financial Results and Provides Corporate Update

    BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended June 30, 2021 and provides a corporate update.

  • PR Newswire

    BioLineRx to Report Second Quarter 2021 Results on August 18, 2021

    BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its unaudited financial results for the quarter ended June 30, 2021 on Wednesday, August 18, 2021, before the US markets open.

  • Insider Monkey

    Is Bioline RX Ltd (BLRX) A Good Stock To Buy?

    The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F filings […]